Welcome To Nuvilex Inc HUB On AGORACOM

Edit this title from the Fast Facts Section

Free
AGORACOM NEWS FLASH

ATTENTION MEMBERS: 

Tonight, we're giving our website a serious makeover.  

So if you can't access the site for a bit, don't worry, we're just sprucing things up for an even smoother experience.  

In the event that you experience issues accessing the new site, please clear your browser's cookies and cache. 

See You On The Other Side!

Message: The Wrong Direction

You've got it right, investors were not impressed with the last CC.

Like you, I have enough not to be hit too hard should this deteriorate to subpenny. Will hold too, for now.

That Last Shot being the major support with its only sale at CC time is something of a cold shower. For me, the abandon of purEffect for future royalties should the product become popular, was a big disappointment.

I agree, at least, the CEO is not giving false hope about OraPhyte.

Wondering how many believe the $3 million revenue predicted...

.022

go

Share
New Message
Please login to post a reply